Virtus Fund Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Virtus Fund Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$11.3M	Sell	184,426 -5,148	-3%	-$322K	0.11%	175
2017 Q3	$12.1M	Sell	189,574 -53,996	-22%	-$3.15M	0.12%	181
2017 Q2	$13.7M	Sell	243,570 -22,391	-8%	-$1.22M	0.14%	192
2017 Q1	$14.5M	Sell	265,961 -3,026	-1%	-$166K	0.14%	188
2016 Q4	$15.7M	Sell	268,987 -1,471,813	-85%	-$80.5M	0.13%	178
2016 Q3	$93.9M	Buy	1,740,800 +1,486,206	+584%	+$95.5M	0.83%	31
2016 Q2	$18.9M	Buy	254,594 +248,234	+3,903%	+$17.5M	0.17%	165
2016 Q1	$409K	Hold	6,360	–	–	﹤0.01%	362
2015 Q4	$440K	Hold	6,360	–	–	﹤0.01%	356
2015 Q3	$379K	Hold	6,360	–	–	﹤0.01%	355
2015 Q2	$423K	Hold	6,360	–	–	﹤0.01%	374
2015 Q1	$410K	Sell	6,360 -1,915	-23%	-$120K	﹤0.01%	381
2014 Q4	$488K	Hold	8,275	–	–	﹤0.01%	400
2014 Q3	$424K	Sell	8,275 -14,790	-64%	-$739K	﹤0.01%	432
2014 Q2	$1.12M	Buy	+23,065	New	+$1.14M	0.01%	433

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtus Fund Advisers's BMY Position: Q4 2017 in Review

Virtus Fund Advisers reduced its Bristol-Myers Squibb (BMY) stake by 2.7% in Q4 2017, selling an estimated $322K and leaving 184,426 shares worth $11.3M. The position accounts for 0.11% of the portfolio, ranked #175.

Virtus Fund Advisers first reported a position in BMY in Q2 2014 and has held it in 15 quarters since. The position peaked at $93.9M in Q3 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Virtus Fund Advisers held 184,426 shares of Bristol-Myers Squibb worth $11.3M as of Q4 2017.
Virtus Fund Advisers sold 5,148 Bristol-Myers Squibb shares in Q4 2017, an estimated $322K.
Bristol-Myers Squibb made up 0.11% of Virtus Fund Advisers's portfolio in Q4 2017, its #175 holding.
Virtus Fund Advisers first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 15 quarters since.
Virtus Fund Advisers's Bristol-Myers Squibb position peaked at $93.9M in Q3 2016.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.